Cite
HARVARD Citation
Unger, J. et al. (2023). Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. Journal of the National Cancer Institute. pp. 437-446. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Unger, J. et al. (2023). Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. Journal of the National Cancer Institute. pp. 437-446. [Online].